Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Total Receivables
Avid Bioservices Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avid Bioservices Inc
NASDAQ:CDMO
|
Total Receivables
$30.7m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
27%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Receivables
$11.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Receivables
$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Receivables
$6.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Receivables
$1.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
33%
|
CAGR 10-Years
40%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Receivables
$5.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
See Also
What is Avid Bioservices Inc's Total Receivables?
Total Receivables
30.7m
USD
Based on the financial report for Jan 31, 2024, Avid Bioservices Inc's Total Receivables amounts to 30.7m USD.
What is Avid Bioservices Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
27%
Over the last year, the Total Receivables growth was 22%. The average annual Total Receivables growth rates for Avid Bioservices Inc have been -2% over the past three years , 21% over the past five years , and 27% over the past ten years .